Injective (INJ) surges to a one-year high: Has its bull run begun?
- Injective (INJ) rose 27% to nearly $9.20, its highest level since October 2025, following a meeting between its CEO and U.S. regulatory officials.
- Analysts predict further gains for INJ, with potential targets of $14 or even $80, based on technical patterns and market sentiment.
- The asset’s Relative Strength Index (RSI) is nearing 80, suggesting it may be overbought and could face short-term volatility as it approaches the $9 level.
Source: CryptoPotato
🌍 Updated by GemCrypto
$BTC
#Bitcoin #Crypto
- Injective (INJ) rose 27% to nearly $9.20, its highest level since October 2025, following a meeting between its CEO and U.S. regulatory officials.
- Analysts predict further gains for INJ, with potential targets of $14 or even $80, based on technical patterns and market sentiment.
- The asset’s Relative Strength Index (RSI) is nearing 80, suggesting it may be overbought and could face short-term volatility as it approaches the $9 level.
Source: CryptoPotato
🌍 Updated by GemCrypto
$BTC
#Bitcoin #Crypto